Embedding of active substances in supramolecular systems has as the main goal to ensure
the controlled release of the active ingredients. Whatever the final architecture or entrapment …

Lipid-based drug-delivery nanoparticles, including non-lamellar-type, mesophasic
nanostructured materials of lyotropic liquid crystals (LLCs), have been a topic of interest for …

Nonlamellar lyotropic liquid crystalline (LLC) lipid nanomaterials have emerged as a
promising class of advanced materials for the next generation of nanomedicine, comprising …

The lipid cubic phase or in meso method is a robust approach for crystallizing membrane
proteins for structure determination. The uptake of the method is such that it is experiencing …

Lyotropic liquid crystal systems, such as reversed bicontinuous cubic and hexagonal
mesophases, are attracting more and more attention because of their unique microstructures …

The overarching goal of this feature article is to review the recent developments in the field
of drug delivery specifically involving colloidal lyotropic liquid crystalline dispersions. The …

The objective of this study was to prepare cubosomal nanoparticles containing a hydrophilic
anticancer drug 5-fluorouracil (5-FU) for liver targeting. Cubosomal dispersions were …

Nonlamellar liquid crystalline phases are attractive platforms for drug solubilization and
targeted delivery. The attractiveness of this formulation principle is linked to the …

Liquid crystal (LC) dosage forms, particularly those using lipid-based lyotropic LCs (LLCs),
have generated considerable interest as potential drug delivery systems. LCs have the …

Lipid-based lyotropic liquid crystals, also referred to as reversed liquid crystalline
mesophases, such as bicontinuous cubic, hexagonal or micellar cubic phases, have …